Latest Breaking News On - Corbus pharmaceuticals daily - Page 2 : comparemela.com

Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews com

Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Mirae asset global investments coSecurities exchange commissionCorbus pharmaceuticals holdings incCorbus pharmaceuticalsJefferies financial groupCorbus pharmaceuticals price performanceNews ratings for corbus pharmaceuticals dailyCorbus pharmaceuticals company profileExchange commissionGet free reportCormorant asset managementAsset global investmentsCorbus pharmaceuticals holdingsFree reportPharmaceuticals holdingsCorbus pharmaceuticals daily

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60 00 Price Target at Oppenheimer

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60 00 Price Target at Oppenheimer
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Corbus pharmaceuticalsMirae asset global investments coJefferies financial groupNews ratings for corbus pharmaceuticals dailyCorbus pharmaceuticals holdings incInstitutional trading of corbus pharmaceuticalsCorbus pharmaceuticals stockSecurities exchange commissionFree reportFinancial groupGet free reportCormorant asset managementExchange commissionAsset global investmentsCorbus pharmaceuticals holdingsPharmaceuticals holdings

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Raised to $60 00 at Oppenheimer

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Raised to $60 00 at Oppenheimer
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jefferies financial groupCorbus pharmaceuticals holdings incHedge funds weigh in on corbus pharmaceuticalsNews ratings for corbus pharmaceuticals dailyCorbus pharmaceuticals stockExchange commissionCorbus pharmaceuticalsGet free reportFinancial groupCormorant asset managementCorbus pharmaceuticals holdingsFree reportPharmaceuticals holdingsCorbus pharmaceuticals daily

Short Interest in Corbus Pharmaceuticals Holdings, Inc (NASDAQ:CRBP) Expands By 560 9%

Short Interest in Corbus Pharmaceuticals Holdings, Inc (NASDAQ:CRBP) Expands By 560 9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News ratings for corbus pharmaceuticals dailyHedge funds weigh in on corbus pharmaceuticalsInsider activity at corbus pharmaceuticalsCorbus pharmaceuticals holdings incCorbus pharmaceuticalsCorbus pharmaceuticals price performanceVident investment advisoryJefferies financial groupBlackrock incRenaissance technologiesCorbus pharmaceuticals holdingsGet free reportFinancial groupCormorant asset managementSigma investmentsStreet corp

Short Interest in Corbus Pharmaceuticals Holdings, Inc (NASDAQ:CRBP) Expands By 560 9%

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 403,800 shares, a growth of 560.9% from the February 29th total of 61,100 shares. Based on an average daily volume of 886,400 […]

Corbus pharmaceuticalsInsider activity at corbus pharmaceuticalsHedge funds weigh in on corbus pharmaceuticalsBlackrock incCorbus pharmaceuticals price performanceCorbus pharmaceuticals holdings incNews ratings for corbus pharmaceuticals dailyRenaissance technologiesJefferies financial groupVident investment advisoryCorbus pharmaceuticals holdingsGet free reportFinancial groupCormorant asset managementSigma investmentsStreet corp